labcorp america hold
labcorp america lead provid diagnost test inform servic
result better expect ep beat consensu driven margin
expans solid organ revenu growth contribut project
launchpad cost control activ lh enter strong foot
carryov benefit sever acquisit paml mt sinai chiltern
drive high-singl low double-digit revenu growth despit reimburs
cut diagnost busi continu move forward cost
control effort anoth billion-plu expect free cash gener lh
varieti capit alloc option deliv sharehold
valu ultim outcom rate cut pama remain wildcard
believ lh capabl navig environ irrespect outcom
maintain buy rate rais price target
ep street consensu
estim upper end guidanc beat vi -- vi model
primarili function higher forecast adjust oper margin
gross margin specif key driver revenu
line estim consensu
labcorp diagnost revenu effect line
estim
test volum increas versu forecast upsid
organ volum growth vs partial off-set lower
contribut vs
revenu per requisit grew vs estim
said benefit acquisit mix continu
tailwind well foreign currenc provid bp boost growth
covanc drug develop revenu y/i also
effect line estim constant currenc
basi revenu increas fx provid bp tailwind
quarter constant currenc increas function chiltern
acquisit contribut first full quarter part compani
